Arcus Biosciences, Inc. (RCUS)
18.99
-0.49
(-2.52%)
USD |
NYSE |
Feb 20, 16:00
18.99
0.00 (0.00%)
Pre-Market: 20:00
Arcus Biosciences Total Assets (Quarterly) : 974.00M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 59.02B |
| Eli Lilly & Co. | 112.48B |
| Merck & Co., Inc. | -- |
| Madrigal Pharmaceuticals, Inc. | 1.260B |
| Janux Therapeutics, Inc. | 1.025B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 538.00M |
| Shareholders Equity (Quarterly) | 436.00M |
| Debt to Equity Ratio | 0.2546 |
| Current Ratio | 3.647 |
| Net Debt Paydown Yield | -1.37% |